Dose-Dependent Therapeutic Distinction between Active and Passive Targeting Revealed Using Transferrin-Coated PGMA Nanoparticles
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dose-Dependent Therapeutic Distinction between Active and Passive Targeting Revealed Using Transferrin-Coated PGMA Nanoparticles
Authors
Keywords
-
Journal
Small
Volume 12, Issue 3, Pages 351-359
Publisher
Wiley
Online
2015-11-30
DOI
10.1002/smll.201502730
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
- (2013) Roy van der Meel et al. ADVANCED DRUG DELIVERY REVIEWS
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer
- (2013) Wenjin Xu et al. BIOMATERIALS
- Castration-Resistant Prostate Cancer: AUA Guideline
- (2013) Michael S. Cookson et al. JOURNAL OF UROLOGY
- Induced clustered nanoconfinement of superparamagnetic iron oxide in biodegradable nanoparticles enhances transverse relaxivity for targeted theranostics
- (2013) Ragy R. T. Ragheb et al. MAGNETIC RESONANCE IN MEDICINE
- Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface
- (2013) Anna Salvati et al. Nature Nanotechnology
- Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
- (2013) Stefan Tenzer et al. Nature Nanotechnology
- Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
- (2013) T Karantanos et al. ONCOGENE
- Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron
- (2012) M. Aapro et al. ANNALS OF ONCOLOGY
- A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics
- (2012) Stephanie D. Steichen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401
- (2012) William Kevin Kelly et al. JOURNAL OF CLINICAL ONCOLOGY
- Annotating MYC status with 89Zr-transferrin imaging
- (2012) Jason P Holland et al. NATURE MEDICINE
- Biomolecular coronas provide the biological identity of nanosized materials
- (2012) Marco P. Monopoli et al. Nature Nanotechnology
- Epidermal Growth Factor-Ferritin H-Chain Protein Nanoparticles for Tumor Active Targeting
- (2012) Xu Li et al. Small
- Multimodal Analysis of PEI-Mediated Endocytosis of Nanoparticles in Neural Cells
- (2011) Cameron W. Evans et al. ACS Nano
- Targeted Biocompatible Nanoparticles for the Delivery of (−)-Epigallocatechin 3-Gallate to Prostate Cancer Cells
- (2011) Vanna Sanna et al. JOURNAL OF MEDICINAL CHEMISTRY
- PC3 is a cell line characteristic of prostatic small cell carcinoma
- (2011) Sheng Tai et al. PROSTATE
- A Reexamination of Active and Passive Tumor Targeting by Using Rod-Shaped Gold Nanocrystals and Covalently Conjugated Peptide Ligands
- (2010) Xiaohua Huang et al. ACS Nano
- To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
- (2010) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Drug resistance in metastatic castration-resistant prostate cancer
- (2010) Bostjan Seruga et al. Nature Reviews Clinical Oncology
- Bypass Mechanisms of the Androgen Receptor Pathway in Therapy-Resistant Prostate Cancer Cell Models
- (2010) Rute B. Marques et al. PLoS One
- Understanding biophysicochemical interactions at the nano–bio interface
- (2009) Andre E. Nel et al. NATURE MATERIALS
- Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
- (2009) C. H. J. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cells
- (2009) Mikhail G. Dozmorov et al. PROSTATE
- Active targeting schemes for nanoparticle systems in cancer therapeutics
- (2008) James D. Byrne et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles
- (2008) S. Dhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now